{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:03:39Z","timestamp":1789571019243,"version":"build-2803163510"},"reference-count":32,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjod"],"DOI":"10.4274\/tjod.galenos.2026.49475","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:57:55Z","timestamp":1786525075000},"source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant human papillomavirus vaccination after excisional treatment for cervical precancer"],"prefix":"10.4274","author":[{"given":"S\u00fcleyman","family":"\u00d6zen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"G\u00fcner \u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclin","family":"\u00d6zuyar \u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130nci","family":"Ba\u015fk\u0131r \u0130\u015flek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Sanc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ijc.26349","article-title":"Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following exci-sional treatment","volume":"131","author":"Kreimer","year":"2012","unstructured":"1. Kreimer AR, Schiffman M, Herrero R, Hildesheim A, Gonz\u00e1lez P, Burk RD, et al. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following exci-sional treatment. Int J Cancer. 2012;131:211-8.","journal-title":"Int J Cancer"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.30623","article-title":"Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): a systematic review","volume":"141","author":"Hoffman","year":"2017","unstructured":"2. Hoffman SR, Le T, Lockhart A, Sanusi A, Dal Santo L, Davis M, et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): a systematic review. Int J Cancer. 2017;141:8-23.","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.3390\/diagnostics15192512","article-title":"CIN2 in the era of risk-based management and HPV vaccination: epidemiology, natural history and guidelines","volume":"15","author":"Bruno","year":"2025","unstructured":"3. Bruno MT, Pagana A, Lo Giudice C, Panella MM, Mascellino G, Lagan\u00e0 AS. CIN2 in the era of risk-based management and HPV vaccination: epidemiology, natural history and guidelines. Diagnostics (Basel). 2025;15:2512.","journal-title":"Diagnostics (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.5468\/ogs.20049","article-title":"Risk factors for type-specific persis-tence of high-risk human papillomavirus and residual\/recurrent cervical intraepithelial neo-plasia after surgical treatment","volume":"63","author":"Ouh","year":"2020","unstructured":"4. Ouh YT, Cho HW, Kim SM, Min KJ, Lee SH, Song JY, et al. Risk factors for type-specific persis-tence of high-risk human papillomavirus and residual\/recurrent cervical intraepithelial neo-plasia after surgical treatment. Obstet Gynecol Sci. 2020;63:631-42.","journal-title":"Obstet Gynecol Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.3390\/cancers13153664","article-title":"Human papil-lomavirus same genotype persistence and risk of cervical intraepithelial neoplasia2+ recur-rence","volume":"13","author":"Iacobone","year":"2021","unstructured":"5. Iacobone AD, Radice D, Sandri MT, Preti EP, Guerrieri ME, Vidal Urbinati AM, et al. Human papil-lomavirus same genotype persistence and risk of cervical intraepithelial neoplasia2+ recur-rence. Cancers (Basel). 2021;13:3664.","journal-title":"Cancers (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2469410","DOI":"10.1080\/21645515.2025.2469410","article-title":"Factors associated with CIN2-3 recurrence: a single center retro-spective analysis","volume":"21","author":"ZY","year":"2025","unstructured":"6. Li ZY, Wang K, Shen XL, Li Q. Factors associated with CIN2-3 recurrence: a single center retro-spective analysis. Hum Vaccin Immunother. 2025;21:2469410.","journal-title":"Hum Vaccin Immunother"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"8130373","DOI":"10.1155\/2022\/8130373","article-title":"Extensive HPV genotyping reveals high association between multiple infections and cervical lesions in Chinese women","volume":"2022","author":"Zhong","year":"2022","unstructured":"7. Zhong F, Yu T, Ma X, Wang S, Cong Q, Tao X. Extensive HPV genotyping reveals high association between multiple infections and cervical lesions in Chinese women. Dis Markers. 2022;2022:8130373.","journal-title":"Dis Markers"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/vaccines9050410","article-title":"Adjuvant HPV vaccination to prevent recurrent cervical dysplasia after surgical treatment: a meta-analysis","volume":"9","author":"Di Donato","year":"2021","unstructured":"8. Di Donato V, Caruso G, Petrillo M, Kontopantelis E, Palaia I, Perniola G, et al. Adjuvant HPV vaccination to prevent recurrent cervical dysplasia after surgical treatment: a meta-analysis. Vaccines (Basel). 2021;9:410.","journal-title":"Vaccines (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/sextrans-2023-055793","article-title":"Timing of HPV vaccination as adjuvant treatment of CIN2+ recurrence in women undergoing surgical ex-cision: a meta-analysis and meta-regression","volume":"99","author":"Petr\u00e1\u0161","year":"2023","unstructured":"9. Petr\u00e1\u0161 M, Dvo\u0159\u00e1k V, Lomozov\u00e1 D, M\u00e1\u010dal\u00edk R, Neradov\u00e1 S, Dlouh\u00fd P, et al. Timing of HPV vac-cination as Petr\u00e1\u0161 M, Dvo\u0159\u00e1k V, Lomozov\u00e1 D, M\u00e1\u010dal\u00edk R, Neradov\u00e1 S, Dlouh\u00fd P, et al. Timing of HPV vaccination as adjuvant treatment of CIN2+ recurrence in women undergoing surgical ex-cision: a meta-analysis and meta-regression. Sex Transm Infect. 2023;99:561-70.","journal-title":"Sex Transm Infect"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1186\/s12879-020-05560-z","article-title":"Impact of HPV-16\/18 AS04-adjuvanted vac-cine on preventing subsequent infection and disease after excision treatment: post-hoc analy-sis from a randomized controlled trial","volume":"20","author":"Zhao","year":"2020","unstructured":"10. Zhao S, Hu S, Xu X, Zhang X, Pan Q, Chen F, et al. Impact of HPV-16\/18 AS04-adjuvanted vac-cine on preventing subsequent infection and disease after excision treatment: post-hoc analy-sis from a randomized controlled trial. BMC Infect Dis. 2020;20:846.","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Cao Q, Hou Y, Wang C, Yin J. Effect of human papillomavirus (HPV) vaccination on HPV infec-tion and recurrence of HPV related disease after local surgical treatment: a systematic review and meta-analysis. PLoS One. 2024;19:e0312128.","DOI":"10.1371\/journal.pone.0312128"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"113994","DOI":"10.1016\/j.ejogrb.2025.113994","article-title":"Impact of hu-man papillomavirus 9-valent vaccine on viral clearance after surgical treatment: a single-center retrospective observational study","volume":"310","author":"Palumbo","year":"2025","unstructured":"12. Palumbo M, Lavitola G, Di Filippo C, Foreste V, Granata M, Imperatore O, et al. Impact of hu-man papillomavirus 9-valent vaccine on viral clearance after surgical treatment: a single-center retrospective observational study. Eur J Obstet Gynecol Reprod Biol. 2025;310:113994.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/vaccines14010044","article-title":"HPV vaccination and HPV outcomes after LEEP: a retro-spective population-based cohort study from Northern Norway, 2022-2024","volume":"14","author":"S\u00f8rbye","year":"2025","unstructured":"13. S\u00f8rbye SW, Antonsen M, Richardsen E. HPV vaccination and HPV outcomes after LEEP: a retro-spective population-based cohort study from Northern Norway, 2022-2024. Vaccines (Basel). 2025;14:44.","journal-title":"Vaccines (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/vaccines8040717","article-title":"As-sessing the long-term role of vaccination against HPV after loop electrosurgical excision proce-dure (LEEP): a propensity-score matched comparison","volume":"8","author":"Bogani","year":"2020","unstructured":"14. Bogani G, Raspagliesi F, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T, et al. As-sessing the long-term role of vaccination against HPV after loop electrosurgical excision proce-dure (LEEP): a propensity-score matched comparison. Vaccines (Basel). 2020;8:717.","journal-title":"Vaccines (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/cancers12051164","article-title":"a prospective pilot observational study in Greek women","volume":"12","author":"Valasoulis","year":"2020","unstructured":"15. Valasoulis G, Pouliakis A, Michail G, Kottaridi C, Spathis A, Kyrgiou M, et al. Alterations of HPV-related biomarkers after prophylactic HPV vaccination. a prospective pilot observational study in Greek women. Cancers (Basel). 2020;12:1164.","journal-title":"Cancers (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1016\/j.vaccine.2020.07.055","article-title":"Prophylactic HPV vaccination af-ter conization: a systematic review and meta-analysis","volume":"38","author":"Jentschke","year":"2020","unstructured":"16. Jentschke M, Kampers J, Becker J, Sibbertsen P, Hillemanns P. Prophylactic HPV vaccination af-ter conization: a systematic review and meta-analysis. Vaccine. 2020;38:6402-9.","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ygyno.2018.08.033","article-title":"SPERANZA project: HPV vac-cination after treatment for CIN2","volume":"151","author":"Ghelardi","year":"2018","unstructured":"17. Ghelardi A, Parazzini F, Martella F, Pieralli A, Bay P, Tonetti A, et al. SPERANZA project: HPV vac-cination after treatment for CIN2. Gynecol Oncol. 2018;151:229-34.","journal-title":"Gynecol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/v17101377","article-title":"Impact of vaccinating adult wom-en who are HPV-positive or with confirmed cervical SIL with the 9-valent vaccine-a systematic review","volume":"17","author":"Pruski","year":"2025","unstructured":"18. Pruski D, Millert-Kali\u0144ska S, Jach R, \u017burawski J, Przybylski M. Impact of vaccinating adult wom-en who are HPV-positive or with confirmed cervical SIL with the 9-valent vaccine-a systematic review. Viruses. 2025;17:1377.","journal-title":"Viruses"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/AOG.0000000000006113","article-title":"Effect of prior 9-valent human papillomavirus vaccination on subsequent lower genital tract dysplasia after cervical excision-al surgery","volume":"147","author":"Joura","year":"2026","unstructured":"19. Joura E, Kjaer SK, Bautista O, Luxembourg A, Saah A, Giuliano A. Effect of prior 9-valent human papillomavirus vaccination on subsequent lower genital tract dysplasia after cervical excision-al surgery. Obstet Gynecol. 2026;147:73-82.","journal-title":"Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/ijc.30391","article-title":"Prior human papillomavirus-16\/18 AS04-adjuvanted vaccination prevents recur-rent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial","volume":"139","author":"SM","year":"2016","unstructured":"20. Garland SM, Paavonen J, Jaisamrarn U, Naud P, Salmer\u00f3n J, Chow SN, et al.; HPV PATRICIA Study Group. Prior human papillomavirus-16\/18 AS04-adjuvanted vaccination prevents recur-rent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial. Int J Cancer. 2016;139:2812-26.","journal-title":"Int J Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/vaccines14020141","article-title":"Impact of adjuvant nonavalent HPV vaccination on viral clearance in HPV-positive women with and without excisional treatment: a retrospective cohort study","volume":"14","author":"AD","year":"2026","unstructured":"21. Erkmen AD, Arkan K. Impact of adjuvant nonavalent HPV vaccination on viral clearance in HPV-positive women with and without excisional treatment: a retrospective cohort study. Vaccines (Basel). 2026;14:141.","journal-title":"Vaccines (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/jcm15031241","article-title":"Dynamics of cervical lesions after excisional treatment in relation to HPV genotypes and cytological findings","volume":"15","author":"Carp","year":"2026","unstructured":"22. Carp CE, Carp A, Gemanariu RM, Marin MG, Anton SC, Elicona H, et al. Dynamics of cervical lesions after excisional treatment in relation to HPV genotypes and cytological findings. J Clin Med. 2026;15:1241.","journal-title":"J Clin Med"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Kapp P, Schmucker C, Siemens W, Brugger T, Gorenflo L, R\u00f6bl- Mathieu M, et al. Human papil-lomavirus (HPV) vaccination in women with conisation. Cochrane Database Syst Rev. 2025;9:CD016121.","DOI":"10.1002\/14651858.CD016121"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1748972","DOI":"10.3389\/fonc.2026.1748972","article-title":"Impact of HPV vaccine on CIN2+ recurrence after conization: a systematic review and meta-analysis of vac-cination timing, valency and surgical margins","volume":"16","author":"Maiorano","year":"2026","unstructured":"24. Maiorano MFP, Cazzolla A, Maiorano BA, Loizzi V, Cormio G, Colonna G, et al. Impact of HPV vaccine on CIN2+ recurrence after conization: a systematic review and meta-analysis of vac-cination timing, valency and surgical margins. Front Oncol. 2026;16:1748972.","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1002\/ijc.70366","article-title":"Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): a randomized, double-blind, placebo-controlled trial","volume":"158","author":"Stankiewicz Karita","year":"2026","unstructured":"25. Stankiewicz Karita HC, Magaret AS, Doody DR, Schouten JT, Mao C, Huh WK, et al. Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): a randomized, double-blind, placebo-controlled trial. Int J Cancer. 2026;158:2983-94.","journal-title":"Int J Cancer"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/aogs.70128","article-title":"HPV vaccination fol-lowing cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression","volume":"105","author":"Eriksen","year":"2026","unstructured":"26. Eriksen DO, Krog L, Ostenfeld EB, Jensen PT, Lycke KD, Gr\u00f8nborg TK, et al. HPV vaccination fol-lowing cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression. Acta Obstet Gynecol Scand. 2026;105:377-85.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2567704","DOI":"10.1080\/21645515.2025.2567704","article-title":"HPV vaccination efficacy in primary and tertiary prevention of vulvar and vaginal HPV-related high grade dysplasia and cancers: a sys-tematic review","volume":"21","author":"Montero-Mac\u00edas","year":"2025","unstructured":"27. Montero-Mac\u00edas R, Adam M, Rouzier R, Bonneau C. HPV vaccination efficacy in primary and tertiary prevention of vulvar and vaginal HPV-related high grade dysplasia and cancers: a sys-tematic review. Hum Vaccin Immunother. 2025;21:2567704.","journal-title":"Hum Vaccin Immunother"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/v15071440","article-title":"Recent developments in human papillomavirus (HPV) vaccinology","volume":"15","author":"Williamson","year":"2023","unstructured":"28. Williamson AL. Recent developments in human papillomavirus (HPV) vaccinology. Viruses. 2023;15:1440.","journal-title":"Viruses"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13027-023-00547-2","article-title":"Can prophylactic HPV vaccination reduce the recurrence of cervical lesions af-ter surgery? Review and prospect","volume":"18","author":"Han","year":"2023","unstructured":"29. Han L, Zhang B. Can prophylactic HPV vaccination reduce the recurrence of cervical lesions af-ter surgery? Review and prospect. Infect Agent Cancer. 2023;18:66.","journal-title":"Infect Agent Cancer"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1591297","DOI":"10.3389\/fimmu.2025.1591297","article-title":"Immune responses to human papillomavirus infection and vaccination","volume":"16","author":"Kiamba","year":"2025","unstructured":"30. Kiamba EW, Goodier MR, Clarke E. Immune responses to human papillomavirus infection and vaccination. Front Immunol. 2025;16:1591297.","journal-title":"Front Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ygyno.2013.05.033","article-title":"HPV vaccine cross-protection: highlights on addi-tional clinical benefit","volume":"130","author":"De Vincenzo","year":"2013","unstructured":"31. De Vincenzo R, Ricci C, Conte C, Scambia G. HPV vaccine cross-protection: highlights on addi-tional clinical benefit. Gynecol Oncol. 2013;130:642-51.","journal-title":"Gynecol Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ijgo.16120","article-title":"Prophylac-tic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion","volume":"169","author":"Bizzarri","year":"2025","unstructured":"32. Bizzarri N, Kyrgiou M, De Vincenzo R, Zapardiel I, Razumova Z, Taumberger N, et al. Prophylac-tic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion. Int J Gynaecol Obstet. 2025;169:597-604.","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Journal of Turkish Society of Obstetric and Gynecology"],"original-title":[],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:19:44Z","timestamp":1789568384000},"score":1,"resource":{"primary":{"URL":"https:\/\/tjoddergisi.org\/articles\/adjuvant-human-papillomavirus-vaccination-after-excisional-treatment-for-cervical-precancer\/doi\/tjod.galenos.2026.49475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":32,"URL":"https:\/\/doi.org\/10.4274\/tjod.galenos.2026.49475","relation":{},"ISSN":["1307-699X","1307-699X"],"issn-type":[{"value":"1307-699X","type":"print"},{"value":"1307-699X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}